Clinical trials: DRAP seeks suggestions on revision of guidelines by 22nd
ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has asked all the stakeholders to send their suggestions...
Subscribing is the best way to get our best stories immediately.